Optimistic Buy Rating for Ocular Therapeutix Amid Early-Stage NPDR Study and Wet AMD Potential
TipRanksApr 22 01:46 ET
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Ocular Therapeutix (OCUL)
TipRanksApr 19 06:30 ET
Ocular Therapeutix Analyst Ratings
BenzingaApr 19 06:27 ET
Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV)
TipRanksApr 17 05:10 ET
Ocular Therapeutix Analyst Ratings
BenzingaApr 16 11:10 ET
Analysts Are Bullish on Top Healthcare Stocks: OptimizeRx (OPRX), Ocular Therapeutix (OCUL)
TipRanksApr 16 00:30 ET
Ocular Therapeutix (OCUL) Gets a Buy From Piper Sandler
TipRanksApr 8 06:37 ET
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Marinus (MRNS) and Halozyme (HALO)
TipRanksApr 8 06:30 ET
Ocular Therapeutix Analyst Ratings
BenzingaMar 13 11:32 ET
HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $15
BenzingaMar 13 06:46 ET
Buy Rating Affirmed for Ocular Therapeutix on Robust Revenue Growth and Clinical Trial Prospects
TipRanksMar 13 06:16 ET
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)
TipRanksMar 13 02:30 ET
TD Cowen Adjusts Price Target on Ocular Therapeutix to $11 From $8, Maintains Market Perform Rating
MT NewswiresMar 12 11:58 ET
Ocular Therapeutix Analyst Ratings
BenzingaMar 12 10:08 ET
Buy Rating Affirmed for Ocular Therapeutix on Strong Phase 3 Results and Strategic Focus
TipRanksMar 12 00:35 ET
Balanced Outlook: Hold Rating on Ocular Therapeutix Amidst Trial Progress and Management Changes
TipRanksMar 11 19:35 ET
Ocular Therapeutix Analyst Ratings
BenzingaFeb 26 09:46 ET
Strategic Leadership and Strong Financials Bolster Buy Rating for Ocular Therapeutix
TipRanksFeb 23 05:19 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Edesa Biotech (EDSA) and Ocular Therapeutix (OCUL)
TipRanksFeb 14 06:30 ET
Ocular Therapeutix Analyst Ratings
BenzingaFeb 14 06:23 ET
No Data
No Data